Novo-Nordisk A/S (NVO)

NYSE: NVO · Pharmaceutical Preparations · Bagsvaerd Denmark, DK · filing with the SEC since 2001

Grade6.9

◀ Past 8.4● Present 7.0▶ Future 5.4

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In millions of Danish kroner (DKK), as filed; per-share figures in Danish kroner; share counts in millions. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Report filed	Feb 4, 2026	Feb 5, 2025	Jan 31, 2024	Feb 1, 2023	Feb 2, 2022	Feb 3, 2021	Feb 5, 2020	Feb 4, 2019
Revenue	309,064	290,403	232,261	176,954	140,800	126,946	122,021	·
Cost of revenue	58,788	44,522	35,765	28,448	23,658	20,932	20,088	·
Gross profit	250,276	245,881	196,496	148,506	117,142	106,014	101,933	·
Research and development	52,039	48,062	32,443	24,047	17,772	15,462	14,220	·
General and administrative	5,969	5,276	4,855	4,467	4,050	3,958	4,007	·
Operating income	127,658	128,339	102,574	74,809	58,644	54,126	52,483	·
Finance costs	6,778	7,346	845	5,986	2,451	2,624	3,995	·
Finance income	9,660	6,198	2,945	239	2,887	1,628	65	·
Share of profit of equity-method investments	0	0	81	0	0	149	0	·
Income before income taxes	130,540	127,191	104,674	69,062	59,080	53,130	48,553	·
Income tax expense	28,106	26,203	20,991	13,537	11,323	10,992	9,602	·
Net income	102,434	100,988	83,683	55,525	47,757	42,138	38,951	·
Earnings per share, basic	23.06	22.67	18.67	12.26^r	10.40^r	9.025^b	8.205^b	·
Earnings per share, diluted	23.03	22.63	18.62	12.22^r	10.37^r	9.005^b	8.19^b	·
Weighted average shares, basic	4,443.0	4,453.9	4,482.8	4,530.6^r	4,593.2^r	4,667.8^b	4,748.6^b	·
Weighted average shares, diluted	4,447.7	4,463.0	4,494.8	4,544.6^r	4,606.2^r	4,680.0^b	4,757.4^b	·

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 2-for-1 split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:Revenue

Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales

Gross profit revenue less the cost of what it soldifrs-full:GrossProfit

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfifrs-full:AdministrativeExpense

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Finance costs what its borrowing costifrs-full:FinanceCosts

Finance income what its cash and investments earnedifrs-full:FinanceIncome

Share of profit of equity-method investments its share of companies it partly ownsifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton NVO · research, not advice